Ethical Issues in Biotechnology — Predicted 2026

AI-Predicted Question Angles for UPSC 2026

Based on trend analysis, current affairs, and recurring themes in Ethical Issues in Biotechnology.

Ethical Governance of Gene Editing (CRISPR)

High

The rapid advancements and accessibility of CRISPR-Cas9 technology, coupled with the ethical controversies like the He Jiankui case, make its governance a critical and evolving area. UPSC is likely to ask about the challenges in regulating such a powerful tool, the distinction between somatic and germline editing, and the international efforts (or lack thereof) to establish ethical boundaries. Questions could focus on the role of national guidelines, the precautionary principle, and the potential for human enhancement versus therapy.

Biotechnology and Health Equity: The Patent Dilemma

Medium to High

The COVID-19 pandemic brought the ethical debate around intellectual property rights and access to essential medicines to the forefront. Discussions at the WTO regarding vaccine patent waivers highlighted the tension between innovation incentives and global health equity. UPSC could frame questions around the TRIPS Agreement, the Doha Declaration, compulsory licensing, and India's role in advocating for equitable access to biotechnological health solutions, particularly for developing nations. This angle connects GS-2, GS-3, and GS-4.

Convergence of AI and Biotechnology: New Ethical Frontiers

Medium

The increasing integration of Artificial Intelligence (AI) with biotechnology, especially in drug discovery, personalized medicine, and genetic data analysis, is creating new ethical challenges. Questions could explore issues like algorithmic bias in genetic diagnostics, privacy and security of vast genomic datasets, accountability for AI-driven medical errors, and equitable access to AI-powered biotech solutions. This represents a forward-looking angle that tests an aspirant's awareness of emerging ethical landscapes at the intersection of cutting-edge technologies.